| Name | Title | Contact Details |
|---|---|---|
Frederic-Andre Vennat |
Executive Director, Program Management Office Lead, Human Health | Profile |
Jacob Langbein |
Director, Global Marketing | Profile |
Greg Elwood |
Associate Director, US Payer Marketing | Profile |
Ali Guerrieri |
Associate Director Consumer Marketing | Profile |
Anoop Kumar |
Director Financial Systems, Life Science | Profile |
Allarity Therapeutics (Nasdaq: ALLR) is a clinical-stage precision medicine company actively advancing a pipeline of in-licensed oncology therapeutics for patients with difficult-to-treat cancers. The company is leveraging its proprietary, highly accurate Drug Response Predictor (DRP®) technology to refine patient selection and improve clinical outcomes. Publicly traded on NASDAQ, Allarity (ALLR) is headquartered in Cambridge, MA, while maintaining an R&D facility in Hoersholm, Denmark. Allarity is committed to enhancing patient outcomes through improved decision-making and personalized cancer care.
Regulatory compliance software solutions, products and services assist pharmaceutical, medical device and biotechnology companies in complying with marketing and sales regulations.
Neotropix is a Malvern, PA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Lewis Drug is a Sioux Falls, SD-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Chemica Technologies Inc is a Beaverton, OR-based company in the Healthcare, Pharmaceuticals, and Biotech sector.